ClearPoint Neuro Inc vs JPMorgan Ultra Short Income ETF — how do they compare? ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M), while JPMorgan Ultra Short Income ETF trades at $50.46. The key difference: ClearPoint Neuro Inc is trading nearer its 52-week high, JPMorgan Ultra Short Income ETF nearer its low. Which is the better fit depends on your goals.
| CLPT | JPST | |
|---|---|---|
Market Cap | $454.21M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $29.60 | $50.78 |
52-Week Low | $8.66 | $50.40 |
Enterprise Value | $488.79M | — |
Trailing returns across standard periods
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.
Read more on JPST →